ArticleBlood cancer journal2023

SRSF2 mutation reduces polycythemia and impairs hematopoietic progenitor functions in JAK2V617F-driven myeloproliferative neoplasm.

Yue Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.